Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy

Journal of Cardiology

Volumn 66, Issue 1, 2015, Pages 57-62

  Sedehi, Daniel ^a   Finocchiaro, Gherardo ^a   Tibayan, Yen ^a   Chi, Jeffrey ^a   Pavlovic, Aleksandra ^a   Kim, Young M ^a   Tibayan, Frederick A ^a   Reitz, Bruce A ^a   Robbins, Robert C ^a   Woo, Joseph ^a   Ha, Richard ^a   Lee, David P ^a   Ashley, Euan A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol septal ablation; Hypertrophic cardiomyopathy; Long term outcomes; Septal myectomy

Indexed keywords

ABLATION THERAPY; ADULT; ALCOHOL SEPTAL ABLATION; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART SURGERY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MITRAL VALVE REGURGITATION; OUTCOME ASSESSMENT; PROGNOSIS; SEPTAL MYECTOMY; SHORT TERM SURVIVAL; STANDARDIZED MORTALITY RATIO; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART VENTRICLE SEPTUM; LONGITUDINAL STUDY; MORTALITY; PATHOPHYSIOLOGY; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

CALIFORNIA; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ECHOCARDIOGRAPHY; FEMALE; HEART SEPTUM; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84930902424     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.08.010     Document Type: Article

References (35)

1. Maron B.J., Casey S.A., Poliac L.C., Gohman T.E., Almquist A.K., Aeppli D.M. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999, 281:650-655.
2. Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., Cecchi F., Maron B.J. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003, 348:295-303.
3. Morrow A.G., Brockenbrough E.C. Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy. Ann Surg 1961, 154:181-189.
4. Robbins R.C., Stinson E.B. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 1996, 111:586-594.
5. Ommen S.R., Maron B.J., Olivotto I., Maron M.S., Cecchi F., Betocchi S., Gersh B.J., Ackerman M.J., McCully R.B., Dearani J.A., Schaff H.V., Danielson G.K., Tajik A.J., Nishimura R.A. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005, 46:470-476.
6. Ralph-Edwards A., Woo A., McCrindle B.W., Shapero J.L., Schwartz L., Rakowski H., Wigle E.D., Williams W.G. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg 2005, 129:351-358.
7. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995, 346:211-214.
8. Alam M., Dokainish H., Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol 2006, 19:319-327.
9. Qin J.X., Shiota T., Lever H.M., Kapadia S.R., Sitges M., Rubin D.N., Bauer F., Greenberg N.L., Agler D.A., Drinko J.K., Martin M., Tuzcu E.M., Smedira N.G., Lytle B., Thomas J.D. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001, 38:1994-2000.
10. Firoozi S., Elliott P.M., Sharma S., Murday A., Brecker S.J., Hamid M.S., Sachdev B., Thaman R., McKenna W.J. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. Eur Heart J 2002, 23:1617-1624.
11. Nagueh S.F., Ommen S.R., Lakkis N.M., Killip D., Zoghbi W.A., Schaff H.V., Danielson G.K., Quinones M.A., Tajik A.J., Spencer W.H. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001, 38:1701-1706.
12. van der Lee C., ten Cate F.J., Geleijnse M.L., Kofflard M.J., Pedone C., van Herwerden L.A., Biagini E., Vletter W.B., Serruys P.W. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets. Circulation 2005, 112:482-488.
13. Mohr R., Schaff H.V., Danielson G.K., Puga F.J., Pluth J.R., Tajik A.J. The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. Experience over 15 years. J Thorac Cardiovasc Surg 1989, 97:666-674.
14. Nagueh S.F., Bierig S.M., Budoff M.J., Desai M., Dilsizian V., Eidem B., Goldstein S.A., Hung J., Maron M.S., Ommen S.R., Woo A. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American Society of Nuclear Cardiology. Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 2011, 24:473-498.
15. Rickham P.P. Human experimentation. Code of ethics of the world medical association. Declaration of Helsinki. Br Med J 1964, 2:177.
16. Holmes D.R., Valeti U.S., Nishimura R.A. Alcohol septal ablation for hypertrophic cardiomyopathy: indications and technique. Catheter Cardiovasc Interv 2005, 66:375-389.
17. Epstein A.E., DiMarco J.P., Ellenbogen K.A., Estes N.A., Freedman R.A., Gettes L.S., Gillinov A.M., Gregoratos G., Hammill S.C., Hayes D.L., Hlatky M.A., Newby L.K., Page R.L., Schoenfeld M.H., Silka M.J., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008, 117:e350-e408.
18. Gregoratos G., Cheitlin M.D., Conill A., Epstein A.E., Fellows C., Ferguson T.B., Freedman R.A., Hlatky M.A., Naccarelli G.V., Saksena S., Schlant R.C., Silka M.J. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: executive summary-a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on pacemaker implantation). Circulation 1998, 97:1325-1335.
19. Pelliccia A., Zipes D.P., Maron B.J. Bethesda Conference #36 and the European Society of Cardiology consensus recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008, 52:1990-1996.
20. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., Shah P.M., Spencer W.H., Spirito P., Ten Cate F.J., Wigle E.D. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the European Society of Cardiology committee for practice guidelines. J Am Coll Cardiol 2003, 42:1687-1713.
21. Finkelstein D.M., Muzikansky A., Schoenfeld D.A. Comparing survival of a sample to that of a standard population. J Natl Cancer Inst 2003, 95:1434-1439.
22. Hardarson T., De la Calzada C.S., Curiel R., Goodwin J.F. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 1973, 2:1462-1467.
23. Shah P.M., Adelman A.G., Wigle E.D., Gobel F.L., Burchell H.B., Hardarson T., Curiel R., De La Calzada C., Oakley C.M., Goodwin J.F. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circ Res 1974, 35(Suppl. II):179-195.
24. Braunwald E., Lambrew C.T., Rockoff S.D., Ross J., Morrow A.G. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 1964, 30(Suppl. 4):3-119.
25. Williams W.G., Wigle E.D., Rakowski H., Smallhorn J., LeBlanc J., Trusler G.A. Results of surgery for hypertrophic obstructive cardiomyopathy. Circulation 1987, 76:V104-V108.
26. Morrow A.G., Reitz B.A., Epstein S.E., Henry W.L., Conkle D.M., Itscoitz S.B., Redwood D.R. Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation 1975, 52:88-102.
27. Schulte H.D., Borisov K., Gams E., Gramsch-Zabel H., Losse B., Schwartzkopff B. Management of symptomatic hypertrophic obstructive cardiomyopathy-long-term results after surgical therapy. Thorac Cardiovasc Surg 1999, 47:213-218.
28. McCully R.B., Nishimura R.A., Tajik A.J., Schaff H.V., Danielson G.K. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 1996, 94:467-471.
29. Dearani J.A., Ommen S.R., Gersh B.J., Schaff H.V., Danielson G.K. Surgery insight: septal myectomy for obstructive hypertrophic cardiomyopathy-the Mayo Clinic experience. Nat Clin Pract Cardiovasc Med 2007, 4:503-512.
30. Alam M., Dokainish H., Lakkis N.M. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis. Eur Heart J 2009, 30:1080-1087.
31. Knight C.J. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Heart 2006, 92:1339-1344.
32. Schonbeck M.H., Brunner-La Rocca H.P., Vogt P.R., Lachat M.L., Jenni R., Hess O.M., Turina M.I. Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. Ann Thorac Surg 1998, 65:1207-1214.
33. Sorajja P., Valeti U., Nishimura R.A., Ommen S.R., Rihal C.S., Gersh B.J., Hodge D.O., Schaff H.V., Holmes D.R. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation 2008, 118:131-139.
34. Seggewiss H., Gleichmann U., Faber L., Fassbender D., Schmidt H.K., Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998, 31:252-258.
35. Fernandes V.L., Nielsen C., Nagueh S.F., Herrin A.E., Slifka C., Franklin J., Spencer W.H. Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. JACC Cardiovasc Interv 2008, 1:561-570.